McKesson Co. (NYSE:MCK) Shares Purchased by Dorsey Wright & Associates
McKesson Co. (NYSE:MCK) Shares Purchased by Dorsey Wright & Associates
Dorsey Wright & Associates raised its position in shares of McKesson Co. (NYSE:MCK – Get Rating) by 41.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,413 shares of the company's stock after purchasing an additional 5,117 shares during the period. McKesson accounts for approximately 1.7% of Dorsey Wright & Associates' holdings, making the stock its 7th biggest position. Dorsey Wright & Associates' holdings in McKesson were worth $5,680,000 at the end of the most recent quarter.
根据Dorsey Wright&Associates最近向美国证券交易委员会提交的13F文件，该公司在第二季度将其在McKesson Co.(纽约证券交易所代码：MCK-GET Rating)的股票头寸提高了41.6%。在此期间，该公司又购买了5,117股，持有该公司17,413股股票。McKesson约占Dorsey Wright&Associates持股的1.7%，使其成为其第7大持仓。截至最近一个季度末，Dorsey Wright&Associates在McKesson持有的股份价值5，68万美元。
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. boosted its stake in McKesson by 2.1% during the 4th quarter. BlackRock Inc. now owns 13,171,252 shares of the company's stock valued at $3,273,976,000 after purchasing an additional 269,506 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of McKesson by 4.1% in the 1st quarter. JPMorgan Chase & Co. now owns 5,965,095 shares of the company's stock worth $1,826,096,000 after acquiring an additional 235,874 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of McKesson by 0.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,976,639 shares of the company's stock worth $605,109,000 after acquiring an additional 5,265 shares during the period. Norges Bank acquired a new stake in shares of McKesson in the 4th quarter worth approximately $386,729,000. Finally, Acadian Asset Management LLC lifted its stake in shares of McKesson by 360.8% in the 1st quarter. Acadian Asset Management LLC now owns 1,077,083 shares of the company's stock worth $329,689,000 after acquiring an additional 843,348 shares during the period. 86.43% of the stock is owned by institutional investors and hedge funds.
其他一些对冲基金和其他机构投资者最近也买卖了该公司的股票。贝莱德股份有限公司在第四季度增持了麦凯森2.1%的股份。贝莱德股份有限公司在此期间增持了269,506股，目前持有该公司13,171,252股股票，价值3,273,976,000美元。摩根大通在第一季度增持了4.1%的McKesson股票。摩根大通在此期间增持了235,874股，目前持有5,965,095股该公司股票，价值1,826,096,000美元。纽约梅隆银行(Bank Of New York Mellon Corp)第一季度增持了0.3%的McKesson股票。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有1,976,639股该公司股票，价值605,109,000美元，在此期间又购买了5,265股。挪威银行在第四季度收购了McKesson公司价值约386,729,000美元的新股份。最后，Acadian Asset Management LLC在第一季度增持了360.8%的McKesson股票。Acadian Asset Management LLC在此期间额外收购了843,348股，目前拥有1,077,083股该公司股票，价值329,689,000美元。86.43%的股票由机构投资者和对冲基金持有。
McKesson Price Performance
麦凯森性价比
McKesson stock traded down $7.53 during trading hours on Thursday, hitting $341.41. The company had a trading volume of 17,551 shares, compared to its average volume of 1,031,360. The firm has a market capitalization of $49.07 billion, a P/E ratio of 35.97, a price-to-earnings-growth ratio of 1.39 and a beta of 0.59. The firm's fifty day moving average is $353.06 and its 200-day moving average is $330.05. McKesson Co. has a fifty-two week low of $193.89 and a fifty-two week high of $375.23.
在周四的交易时段，麦克森的股价下跌了7.53美元，触及341.41美元。该公司成交量为17,551股，而其平均成交量为1,031,360股。该公司的市值为490.7亿美元，市盈率为35.97倍，市盈率为1.39倍，贝塔系数为0.59。该公司的50日移动均线切入位在353.06美元，200日移动均线切入位在330.05美元。McKesson Co.股价跌至52周低点193.89美元，52周高点375.23美元。
McKesson Increases Dividend
麦凯森增加股息
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Thursday, September 1st will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 0.63%. This is an increase from McKesson's previous quarterly dividend of $0.47. The ex-dividend date is Wednesday, August 31st. McKesson's payout ratio is currently 22.83%.
该公司最近还宣布了季度股息，将于10月3日星期一支付。9月1日星期四登记在册的股东将获得0.54美元的股息。这意味着年化股息为2.16美元，收益率为0.63%。这比McKesson之前季度0.47美元的股息有所增加。除息日为8月31日(星期三)。McKesson的派息率目前为22.83%。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
A number of analysts have recently weighed in on the stock. Credit Suisse Group upped their price target on shares of McKesson from $377.00 to $385.00 and gave the stock an "outperform" rating in a research note on Monday, August 8th. Deutsche Bank Aktiengesellschaft upped their price target on shares of McKesson from $378.00 to $409.00 in a research note on Monday, August 8th. Mizuho boosted their target price on shares of McKesson from $331.00 to $345.00 and gave the stock a "neutral" rating in a report on Thursday, August 4th. Argus boosted their target price on shares of McKesson from $370.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, September 12th. Finally, UBS Group boosted their target price on shares of McKesson from $380.00 to $400.00 and gave the stock a "buy" rating in a report on Thursday, August 4th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $352.46.
一些分析师最近对该股进行了加码。瑞士信贷集团将麦凯森股票的目标价从377.00美元上调至385.00美元，并在8月8号周一的一份研究报告中给出了该股“跑赢大盘”的评级。Deutsche Bank Aktiengesellschaft在8月8日周一的一份研究报告中将麦克森的股票目标价从378.00美元上调至409.00美元。瑞穗在8月4日周四的一份报告中将麦克森股票的目标价从331.00美元上调至345.00美元，并给予该股“中性”评级。Argus将McKesson股票的目标价从370.00美元上调至430.00美元，并在9月12日周一的一份报告中给予该股“买入”评级。最后，瑞银集团将麦凯森股票的目标价从380.00美元上调至400.00美元，并在8月4日周四的一份报告中给予该股“买入”评级。一位研究分析师对该股的评级为持有，11位分析师给出了买入评级，一位分析师给出了该公司股票的强力买入评级。根据MarketBeat的数据，该公司目前的共识评级为买入，共识目标价为352.46美元。
Insiders Place Their Bets
内部人士下注
In other McKesson news, EVP Lori A. Schechter sold 7,500 shares of the business's stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $343.94, for a total value of $2,579,550.00. Following the completion of the sale, the executive vice president now directly owns 11,678 shares of the company's stock, valued at $4,016,531.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other McKesson news, EVP Lori A. Schechter sold 7,500 shares of the business's stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $343.94, for a total value of $2,579,550.00. Following the completion of the sale, the executive vice president now directly owns 11,678 shares of the company's stock, valued at $4,016,531.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas L. Rodgers sold 1,300 shares of the business's stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $367.21, for a total transaction of $477,373.00. Following the completion of the sale, the executive vice president now directly owns 2,544 shares of the company's stock, valued at $934,182.24. The disclosure for this sale can be found here. Insiders own 0.21% of the company's stock.
在McKesson的其他新闻，执行副总裁洛里·A·谢克特在9月15日星期四的一笔交易中出售了7500股该公司的股票。这些股票的平均价格为343.94美元，总价值为2579,550.00美元。出售完成后，执行副总裁总裁现在直接持有该公司11678股股票，价值4016531.32美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过此超链接。在McKesson的其他新闻，执行副总裁洛里·A·谢克特在9月15日星期四的一笔交易中出售了7500股该公司的股票。这些股票的平均价格为343.94美元，总价值为2579,550.00美元。出售完成后，执行副总裁总裁现在直接持有该公司11678股股票，价值4016531.32美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过此超链接。此外，执行副总裁托马斯·L·罗杰斯在9月8日星期四的一次交易中出售了1300股该公司的股票。该股以367.21美元的平均价格出售，总成交金额为477,373.00美元。出售完成后，执行副总裁总裁现在直接持有该公司2544股股票，价值934,182.24美元。关于这次销售的披露可以找到这里。内部人士持有该公司0.21%的股份。
McKesson Profile
麦凯森档案
(Get Rating)
(获取评级)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.
McKesson公司在美国和国际上提供医疗服务。它通过四个部门运作：美国制药、国际、医疗-外科解决方案和处方技术解决方案(RxTS)。美国制药部门分销品牌、仿制药、特效药、生物相似药和非处方药以及其他与医疗保健相关的产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on McKesson (MCK)
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- 2 Casino Stocks Worth Taking a Look At
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- A Trio of Q3 Winners With Room to Run
- 免费获取StockNews.com关于McKesson(MCK)的研究报告
- 这家小盘股医疗保健公司的表现好于其指数
- 关于这个熊市，Cintas能教给投资者什么？
- 值得一看的2只赌场股票
- 黑莓股价下跌，业绩再次不温不火
- 第三季度赢家三人组还有运行的空间
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
接受McKesson Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对McKesson和相关公司的最新新闻和分析师评级的每日简要摘要。